Loading page…
Accretion Pharmaceuticals Limited is listed on the NSE. Auto-imported from the exchange master list; profile pending.
No red flags triggered.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
No scheme among the 32 fund houses on record reported a position in Accretion Pharmaceuticals Limited. Portfolios are published monthly by each AMC; coverage is still partial.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Anawil Wire And Engineering LimitedANAWILANAWIL | ₹1,064 Cr | — | — | — | — | — | — | — | — | — |
| Credent Connect N Care LimitedCREDENTCREDENT | ₹696 Cr | — | — | — | — | — | — | — | — | — |
| Metalic Technoforge LimitedMETALICMETALIC | ₹426 Cr | — | — | — | — | — | — | — | — | — |
| Optimystix Entertainment India LimitedOPTIMYSTIXOPTIMYSTIX | ₹307 Cr | — | — | — | — | — | — | — | — | — |
| Pramodini Medicare LimitedPRAMODINIPRAMODINI | ₹254 Cr | ₹271 Cr | ₹62 Cr | — | — | ₹17 Cr | 27.9% | -11.3% | 39.1% | — |
| Annapurna Swadisht LimitedANNAPURNAANNAPURNA | ₹211 Cr | — | ₹520 Cr | ₹72 Cr | 13.9% | ₹32 Cr | 6.2% | — | — | — |
| Fascinate Textiles LimitedFASCINATEFASCINATE | ₹102 Cr | — | — | — | — | — | — | — | — | — |
| Propshop Events And Exhibitions LimitedPROPSHOPPROPSHOP | ₹97 Cr | — | ₹70 Cr | ₹11 Cr | 15.8% | ₹8 Cr | 11.4% | — | — | — |
| Vinod Texworld LimitedVINODVINOD | ₹82 Cr | — | — | — | — | — | — | — | — | — |
| Skytech Infinite Platform LimitedSKYTECHSKYTECH | ₹38 Cr | ₹44 Cr | — | — | — | — | — | — | — | — |
| Dhansa Labs LimitedDHANSADHANSA | — | — | ₹142 Cr | ₹11 Cr | 7.7% | ₹6 Cr | 3.9% | — | — | — |
| Divine Power Energy LimitedDPELDPEL | — | — | ₹626 Cr | ₹51 Cr | 8.1% | ₹27 Cr | 4.3% | — | — | — |
Annual reports, earnings call transcripts and presentations will appear here once ingested.
Corporate actions, results dates and filings will appear here once ingested.
Standalone figures
| Ratio | Mar 2025 | Mar 2026 |
|---|---|---|
| Margins | ||
| Gross margin % | 30.4% | 27.3% |
| EBITDA margin % | 20.7% | 16.7% |
| EBIT margin % | 19.4% | 15.3% |
| PAT margin % | 11.8% | 10.8% |
| Working capital | ||
| Receivable days | — | — |
| Inventory days | 188 | 159 |
| Payable days | — | — |
| NWC days | — | — |
| Leverage | ||
| Current ratio | 1.44 | 2.91 |
| Debt to EBITDA | — | — |
| Debt to equity | — | — |
| Interest coverage | 7.8 | 16.4 |
| Asset turnover | 1.44 | 1.17 |
| Return ratios | ||
| Return on assets % | 17% | 12.6% |
| Return on capital employed % | 67.3% | 38.5% |
| Return on equity % | — | — |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Quarterly shareholding records haven't been ingested for this company.
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| 57 | 90 | |
| COGS | 40 | 65 |
| Gross profit | 17 | 24 |
| 6 | 10 | |
| Operating profit (EBITDA) | 12 | 15 |
| OPM % | 20.7% | 16.7% |
| Depreciation | 1 | 1 |
| Interest | 1 | 1 |
| 0 | 0 | |
| Profit before tax | 10 | 13 |
| Tax | 3 | 3 |
| Tax % | 30.4% | 26.2% |
| 7 | 10 | |
| PAT margin % | 11.8% | 10.8% |
| EPS (₹) | 8.5 | 9 |
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | — | — |
| Reserves | — | — |
| Borrowings | — | — |
| 40 | 77 | |
| Total equity & liabilities | 40 | 77 |
| Fixed assets | 6 | 13 |
| CWIP | — | — |
| Investments | 0 | 0 |
| 34 | 63 | |
| Total assets | 40 | 77 |
| ₹ Cr | Mar 2025 | Mar 2026 |
|---|---|---|
| 6 | -15 | |
| -2 | -9 | |
| -4 | 27 | |
| Net cash flow | -0 | 4 |
| Free cash flow | 4 | -23 |
| CFO / Operating profit % | 49.1% | -97.7% |